Author's details

Name: Sean Ekins
Date registered: April 7, 2011

Latest posts

  1. Seeing through the hype of deep learning for drug discovery — June 26, 2017
  2. A Dying Breed — May 25, 2017
  3. Summer intern for Collaborations Pharmaceuticals — April 20, 2017
  4. Drug Discovery Today Special Issue on Tuberculosis — March 16, 2017
  5. A bit of an update on Collaborations Pharmaceuticals — March 9, 2017

Most commented posts

  1. Beware Rare Disease Foundations – Funding Scam — 16 comments
  2. Collaboration could give us a gold standard database of drugs — 15 comments
  3. Green Chemistry – Solvent selection guide — 11 comments
  4. Lets do it all again updating predictions for the ‘real’ BIA 10-2474 — 10 comments
  5. Survey Overload for Scientists – A Language Discrimination Survey — 9 comments

Author's posts listings


Antimalarial being tested as possible Ebola virus drug -project started with a tweet

Today we announced a new R21 grant from NCATS NIH awarded to Collaborations Pharmaceuticals, Inc andTexas Biomedical Research Institute. This continues the work published in F1000Research . What is missing from the press release and papers etc. is the back story. Why are we working on this and how did it start. Essentially it took …

Continue reading »


Non-classical transpeptidases insights and new antibacterials

Well today’s post has been a few years in gestation and yes I have had to keep it quiet for a long, long time which was extended as our recent paper was embargoed for what seemed like an eternity. It starts back in 2009 when I was using some of the NIAID/SRI whole cell screening …

Continue reading »


OpenZika – PLOS Neglected Tropical Diseases

After several months our article in PLOS Neglected Tropical Diseases is now out from embargo and published. A big thank you to my co-authors Carolina Horta Andrade and Alexander Perryman who have put a lot of their time into the project. I would also like to thank the reviewers for their constructive comments. We have …

Continue reading »


Zika Homology models paper makes it to PubMed >6 months after “Publishing” in F1000Research

Who would have thought in February that when we submitted our manuscript on Zika homology models to F1000Research it would finally appear in PubMed over 6 months later. This was no where near as fast as our first article on Zika that took a few months to be approved and then appear in PubMed. What …

Continue reading »


Postdoc Position for Drug Discovery at Collaborations Pharmaceuticals

Been in start up more fore over a year now I need to hire some help and get an office / lab. Ideally I am looking for a PhD or postdoc that wants to learn what I do for a couple of years. The posting below should describe the role. Feel free to connect (no …

Continue reading »


Progress Through Partnership: The NINDS 2016 Nonprofit Forum

Last tuesday and wednesday (Sept 13-14th)  I was very honored to be an attendee at the “Progress Through Partnership: The NINDS 2016 Nonprofit Forum“. My role was to provide an industry perspective on several panels (alongside Dr. Ronald Marcus, Cerecor). There were a large number of rare disease (patients or parent) advocates, academic scientists and …

Continue reading »


Collaborations Pharma, Inc. And Rutgers Announce NIH Award to Develop Treatments for Tuberculosis

To follow up my last post .. I can now announce some recent funding from NIAID for the TB work with Dr. Joel Freundlich ! Here is the PR – Fuquay-Varina, North Carolina – The National Institute of Allergy and Infectious Diseases (NIAID) recently awarded $149,388 to Collaborations Pharma, Inc. (CPI) to initiate a partnership …

Continue reading »


Gearing up the new company

Well, its been quiet for several weeks as I had a few projects to complete. One was the final report for an SBIR and in addition I have been curating a special edition of Drug Discovery Today focused on Tuberculosis as well as writing grants (I am always writing grants). So lots of writing basically …

Continue reading »


Experience with Reddit Science AMA

Today I took part in a Reddit Science Ask Me Anything (AMA). I had been invited to do this by the nice folks at Springer so I chose rare diseases as my topic and had 100s of questions to answer. This naturally took far longer than 1hr to answer. Generally a good mix of topics …

Continue reading »


MM4TB and a trip to a new Miro Exhibit

  Occasionally I take a bit of a diversion from my usual science focused postings, this one has an artistic flavor. I am in beautiful Brataslava in the Slovak Republic for a few days for the final More Medicines for Tuberculosis (MM4TB) meeting. Every 6 months for the past 5 years we have had meetings of …

Continue reading »

Older posts «

» Newer posts